All Relations between Alzheimer Disease and microtubule-associated protein tau

Publication Sentence Publish Date Extraction Date Species
Erratum to: Ubiquitin Specific Protease 13 Regulates Tau Accumulation and Clearance in Models of Alzheimer's Disease. Journal of Alzheimer's disease : JAD. vol 98. issue 4. 2024-04-19. PMID:38640189. erratum to: ubiquitin specific protease 13 regulates tau accumulation and clearance in models of alzheimer's disease. 2024-04-19 2024-04-22 Not clear
Dennis J Selko. The advent of Alzheimer treatments will change the trajectory of human aging. Nature aging. vol 4. issue 4. 2024-04-19. PMID:38641654. a salient example is the discovery that antibodies to amyloid ß-protein, long debated as a causative factor in alzheimer's disease (ad), clear amyloid plaques, decrease levels of abnormal tau proteins and slow cognitive decline. 2024-04-19 2024-04-22 human
Hsin-Hsi Tsai, Chia-Ju Liu, Bo-Ching Lee, Ya-Fang Chen, Ruoh-Fang Yen, Jiann-Shing Jeng, Li-Kai Tsa. Cerebral tau pathology in cerebral amyloid angiopathy. Brain communications. vol 6. issue 2. 2024-04-19. PMID:38638152. tau, a hallmark of alzheimer's disease, is poorly characterized in cerebral amyloid angiopathy. 2024-04-19 2024-04-21 Not clear
Shan Jiang, Eric J Sydney, Avery M Runyan, Rossana Serpe, Malavika Srikanth, Helen Y Figueroa, Mu Yang, Natura Myek. 5-HT4 receptor agonists treatment reduces tau pathology and behavioral deficit in the PS19 mouse model of tauopathy. Frontiers in cellular neuroscience. vol 18. 2024-04-19. PMID:38638303. accumulation of tau in synapses in the early stages of alzheimer's disease (ad) has been shown to cause synaptic damage, synaptic loss, and the spread of tau pathology through trans-synaptically connected neurons. 2024-04-19 2024-04-21 mouse
Ahmed Imtiaz, Shotaro Shimonaka, Mohammad Nasir Uddin, Montasir Elahi, Koichi Ishiguro, Masato Hasegawa, Nobutaka Hattori, Yumiko Moto. Selection of lansoprazole from an FDA-approved drug library to inhibit the Alzheimer's disease seed-dependent formation of tau aggregates. Frontiers in aging neuroscience. vol 16. 2024-04-18. PMID:38633982. selection of lansoprazole from an fda-approved drug library to inhibit the alzheimer's disease seed-dependent formation of tau aggregates. 2024-04-18 2024-04-20 mouse
BinShu Chai, Yong Wu, HengHui Yang, BiaoFeng Fan, SiYu Cao, XiaoFei Zhang, YaQing Xie, ZhiXiang Hu, ZhongLiang Ma, YunKui Zhang, Wei Pan, Wei Meng, Jiao Meng, WenJuan Tian, JiaLi Zhang, YanLi Li, Yang Shao, ShaoJia Wan. Tau Aggregation-Dependent Lipid Peroxide Accumulation Driven by the hsa_circ_0001546/14-3-3/CAMK2D/Tau Complex Inhibits Epithelial Ovarian Cancer Peritoneal Metastasis. Advanced science (Weinheim, Baden-Wurttemberg, Germany). 2024-04-18. PMID:38634567. therefore, based on this results, ferroptosis caused by tau aggregation occurs in eoc cells, which is not only in alzheimer's disease- or parkinson's disease-related cells and this kind of ferroptosis driven by the hsa_circ_0001546/14-3-3/camk2d/tau complex is lpo-dependent rather than gpx4-dependent is hypothesized. 2024-04-18 2024-04-20 Not clear
Pascual Sánchez-Juan, Elizabeth Valeriano-Lorenzo, Alicia Ruiz-González, Ana Belén Pastor, Hector Rodrigo Lara, Francisco López-González, María Ascensión Zea-Sevilla, Meritxell Valentí, Belen Frades, Paloma Ruiz, Laura Saiz, Iván Burgueño-García, Miguel Calero, Teodoro Del Ser, Alberto Rában. Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles. Brain : a journal of neurology. 2024-04-18. PMID:38634687. a mediation analysis provided additional support for the role of astrocytic activation as a link between amyloid and tau pathology in alzheimer's disease. 2024-04-18 2024-04-20 Not clear
Pascual Sánchez-Juan, Elizabeth Valeriano-Lorenzo, Alicia Ruiz-González, Ana Belén Pastor, Hector Rodrigo Lara, Francisco López-González, María Ascensión Zea-Sevilla, Meritxell Valentí, Belen Frades, Paloma Ruiz, Laura Saiz, Iván Burgueño-García, Miguel Calero, Teodoro Del Ser, Alberto Rában. Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles. Brain : a journal of neurology. 2024-04-18. PMID:38634687. our results contribute to increasing evidence suggesting a role for blood gfap as an alzheimer's disease biomarker, and the findings offer mechanistic insights into the relationship between blood gfap and alzheimer's disease neuropathology, highlighting its ties with tau burden. 2024-04-18 2024-04-20 Not clear
Agneta Nordber. Insights into the progression of genetic Alzheimer's disease from tau PET. The Lancet. Neurology. vol 23. issue 5. 2024-04-17. PMID:38631755. insights into the progression of genetic alzheimer's disease from tau pet. 2024-04-17 2024-04-20 Not clear
Julie K Wisch, Nicole S McKay, Anna H Boerwinkle, James Kennedy, Shaney Flores, Benjamin L Handen, Bradley T Christian, Elizabeth Head, Mark Mapstone, Michael S Rafii, Sid E O'Bryant, Julie C Price, Charles M Laymon, Sharon J Krinsky-McHale, Florence Lai, H Diana Rosas, Sigan L Hartley, Shahid Zaman, Ira T Lott, Dana Tudorascu, Matthew Zammit, Adam M Brickman, Joseph H Lee, Thomas D Bird, Annie Cohen, Patricio Chrem, Alisha Daniels, Jasmeer P Chhatwal, Carlos Cruchaga, Laura Ibanez, Mathias Jucker, Celeste M Karch, Gregory S Day, Jae-Hong Lee, Johannes Levin, Jorge Llibre-Guerra, Yan Li, Francisco Lopera, Jee Hoon Roh, John M Ringman, Charlene Supnet-Bell, Christopher H van Dyck, Chengjie Xiong, Guoqiao Wang, John C Morris, Eric McDade, Randall J Bateman, Tammie L S Benzinger, Brian A Gordon, Beau M Ance. Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study. The Lancet. Neurology. vol 23. issue 5. 2024-04-17. PMID:38631766. comparison of tau spread in people with down syndrome versus autosomal-dominant alzheimer's disease: a cross-sectional study. 2024-04-17 2024-04-20 Not clear
Julie K Wisch, Nicole S McKay, Anna H Boerwinkle, James Kennedy, Shaney Flores, Benjamin L Handen, Bradley T Christian, Elizabeth Head, Mark Mapstone, Michael S Rafii, Sid E O'Bryant, Julie C Price, Charles M Laymon, Sharon J Krinsky-McHale, Florence Lai, H Diana Rosas, Sigan L Hartley, Shahid Zaman, Ira T Lott, Dana Tudorascu, Matthew Zammit, Adam M Brickman, Joseph H Lee, Thomas D Bird, Annie Cohen, Patricio Chrem, Alisha Daniels, Jasmeer P Chhatwal, Carlos Cruchaga, Laura Ibanez, Mathias Jucker, Celeste M Karch, Gregory S Day, Jae-Hong Lee, Johannes Levin, Jorge Llibre-Guerra, Yan Li, Francisco Lopera, Jee Hoon Roh, John M Ringman, Charlene Supnet-Bell, Christopher H van Dyck, Chengjie Xiong, Guoqiao Wang, John C Morris, Eric McDade, Randall J Bateman, Tammie L S Benzinger, Brian A Gordon, Beau M Ance. Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study. The Lancet. Neurology. vol 23. issue 5. 2024-04-17. PMID:38631766. in people with genetic forms of alzheimer's disease, such as in down syndrome and autosomal-dominant alzheimer's disease, pathological changes specific to alzheimer's disease (ie, accumulation of amyloid and tau) occur in the brain at a young age, when comorbidities related to ageing are not present. 2024-04-17 2024-04-20 Not clear
Julie K Wisch, Nicole S McKay, Anna H Boerwinkle, James Kennedy, Shaney Flores, Benjamin L Handen, Bradley T Christian, Elizabeth Head, Mark Mapstone, Michael S Rafii, Sid E O'Bryant, Julie C Price, Charles M Laymon, Sharon J Krinsky-McHale, Florence Lai, H Diana Rosas, Sigan L Hartley, Shahid Zaman, Ira T Lott, Dana Tudorascu, Matthew Zammit, Adam M Brickman, Joseph H Lee, Thomas D Bird, Annie Cohen, Patricio Chrem, Alisha Daniels, Jasmeer P Chhatwal, Carlos Cruchaga, Laura Ibanez, Mathias Jucker, Celeste M Karch, Gregory S Day, Jae-Hong Lee, Johannes Levin, Jorge Llibre-Guerra, Yan Li, Francisco Lopera, Jee Hoon Roh, John M Ringman, Charlene Supnet-Bell, Christopher H van Dyck, Chengjie Xiong, Guoqiao Wang, John C Morris, Eric McDade, Randall J Bateman, Tammie L S Benzinger, Brian A Gordon, Beau M Ance. Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study. The Lancet. Neurology. vol 23. issue 5. 2024-04-17. PMID:38631766. we compared the magnitude, spatial extent, and temporal ordering of tau spread in people with down syndrome and autosomal-dominant alzheimer's disease. 2024-04-17 2024-04-20 Not clear
Zhengyun Han, Xingmao Yang, Shuiqing Huan. Sleep deprivation: A risk factor for the pathogenesis and progression of Alzheimer's disease. Heliyon. vol 10. issue 7. 2024-04-16. PMID:38623196. sleep deprivation promotes aβ deposition and tau hyperphosphorylation, which is a risk factor for the pathogenesis and progression of alzheimer's disease (ad). 2024-04-16 2024-04-18 Not clear
Subha Kalyaanamoorthy, Stanley Kojo Opare, Xiaoxiao Xu, Aravindhan Ganesan, Praveen P N Ra. Post-Translational Modifications in Tau and Their Roles in Alzheimer's Pathology. Current Alzheimer research. 2024-04-16. PMID:38623984. post-translational modifications in tau and their roles in alzheimer's pathology. 2024-04-16 2024-04-18 Not clear
Subha Kalyaanamoorthy, Stanley Kojo Opare, Xiaoxiao Xu, Aravindhan Ganesan, Praveen P N Ra. Post-Translational Modifications in Tau and Their Roles in Alzheimer's Pathology. Current Alzheimer research. 2024-04-16. PMID:38623984. microtubule-associated protein tau (also known as tau) has been shown to accumulate into paired helical filaments and neurofibrillary tangles, which are known hallmarks of alzheimer's disease (ad) pathology. 2024-04-16 2024-04-18 Not clear
Ujjayini Ghosh, Eric Tse, Marie Shi, Hyunjun Yang, Feng Wang, Gregory E Merz, Stanley B Prusiner, Daniel R Southworth, Carlo Condell. Cryo-EM Structures Reveal Tau Filaments from Down Syndrome Adopt Alzheimer's Disease Fold. bioRxiv : the preprint server for biology. 2024-04-15. PMID:38617229. cryo-em structures reveal tau filaments from down syndrome adopt alzheimer's disease fold. 2024-04-15 2024-04-17 Not clear
Hamid Abuwarda, Anne Trainer, Corey Horien, Xilin Shen, Suyeon Ju, R Todd Constable, Carolyn Frederick. Whole-brain functional connectivity predicts groupwise and sex-specific tau PET in preclincal Alzheimer's disease. bioRxiv : the preprint server for biology. 2024-04-15. PMID:38617320. whole-brain functional connectivity predicts groupwise and sex-specific tau pet in preclincal alzheimer's disease. 2024-04-15 2024-04-17 Not clear
Hamid Abuwarda, Anne Trainer, Corey Horien, Xilin Shen, Suyeon Ju, R Todd Constable, Carolyn Frederick. Whole-brain functional connectivity predicts groupwise and sex-specific tau PET in preclincal Alzheimer's disease. bioRxiv : the preprint server for biology. 2024-04-15. PMID:38617320. preclinical alzheimer's disease, characterized by the initial accumulation of amyloid and tau pathologies without symptoms, presents a critical opportunity for early intervention. 2024-04-15 2024-04-17 Not clear
Xiyong Xiang, Siyu Xia, Shan Li, Yirong Zeng, Lixuan Wang, Yan Zho. Study on the role and mechanism of Tan IIA in Alzheimer's disease based on CREB-BDNF-TrkB pathway. Neuroscience letters. 2024-04-14. PMID:38616003. the occurrence and development of alzheimer's disease (ad) is closely related to neuronal loss, inflammatory response, cholinergic imbalance, and tau protein hyperphosphorylation. 2024-04-14 2024-04-17 rat
Peter T Nelson, David W Fardo, Xian Wu, Khine Zin Aung, Matthew D Cykowski, Yuriko Katsumat. Limbic-predominant age-related TDP-43 encephalopathy (LATE-NC): Co-pathologies and genetic risk factors provide clues about pathogenesis. Journal of neuropathology and experimental neurology. 2024-04-13. PMID:38613823. although "pure" late-nc is not rare, late-nc often coexists in the same brains with alzheimer disease neuropathologic change, brain arteriolosclerosis, hippocampal sclerosis of aging, and/or age-related tau astrogliopathy (artag). 2024-04-13 2024-04-16 human